John Waas
- Co-authors
- Keith R. McCraeScot C. RemickAfshin DowlatiKelly M. RobertsonJonathan S. LewinBruce S. StamblerBeth OvermoyerAnne L. Taylor
- Topics
- Cancer Treatment and Pharmacology (3 papers)Angiogenesis and VEGF in Cancer (2 papers)Cancer, Hypoxia, and Metabolism (2 papers)
- Cited by
- HematologyOncologyCancer Research
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
John Waas
6 papers receiving 473 citations
Peers
Comparison fields: 5 of 61
- Molecular Biology 261
- Oncology 193
- Hematology 109
- Cancer Research 87
- Organic Chemistry 72
Countries citing papers authored by John Waas
This map shows the geographic impact of John Waas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Waas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Waas more than expected).
Fields of papers citing papers by John Waas
This network shows the impact of papers produced by John Waas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Waas. The network helps show where John Waas may publish in the future.
Co-authorship network of co-authors of John Waas
This figure shows the co-authorship network connecting the top 25 collaborators of John Waas. A scholar is included among the top collaborators of John Waas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Waas. John Waas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 88 | |
| 3 | 3 | |
| 4 | 30 | |
| 5 | 16 | |
| 6 | A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer. | 347 |
About John Waas
John Waas is a scholar working on Hematology, Oncology and Cancer Research, having authored 6 papers that have together received 487 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Angiogenesis and VEGF in Cancer (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Hematology (109 citations), Oncology (193 citations) and Cancer Research (87 citations). John Waas has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Keith R. McCrae, Scot C. Remick, Afshin Dowlati, Kelly M. Robertson, Jonathan S. Lewin, Bruce S. Stambler, Beth Overmoyer, Anne L. Taylor, John A. Jesberger and Michael R.L. Stratford. Their work appears in journals such as Blood, Clinical Cancer Research and Journal of Vascular Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.